QPQ Tracker BETA
← Back to Influence Map

Johnson & Johnson

Organization

Diversified healthcare conglomerate ($85 billion revenue in 2023). Pharmaceutical division (Janssen) makes Stelara, Darzalex, and Tremfya. Facing ongoing talc litigation.

pharmaceuticals

Given

$0

Received

$152,864,587

Connections

2

Votes

0

Donations Received

DonorAmountDateCycle
Department of Defense$15,745,072Aug 1, 2010
Department of Defense$15,530,462Apr 1, 2009
Department of Defense$15,238,102Oct 1, 2009
Department of Defense$14,719,650Jul 1, 2009
Department of Defense$12,479,372Jul 1, 2010
Department of Defense$11,997,710Jan 1, 2009
Department of Defense$11,803,685Jan 1, 2010
Department of Defense$11,745,063Oct 1, 2010
Department of Defense$11,204,224Jan 1, 2011
Department of Defense$11,042,284Jan 1, 2012
Department of Defense$10,898,180Apr 1, 2011
Department of Defense$10,460,784Apr 1, 2012

Relationships

TypeConnected ToDetailsSource
Coalition withPharmaceutical industryJohnson & Johnson is the largest healthcare company by revenue
Instrument of (target)Johnson & Johnson Employees' Good Government FundJ&J PAC is the political arm of Johnson & Johnson